Livedoid vasculitis - Vasculite Livedoid
https://en.wikipedia.org/wiki/Livedoid_vasculitis
☆ Nos resultados de Stiftung Warentest de Alemaña de 2022, a satisfacción dos consumidores con ModelDerm foi só lixeiramente inferior á das consultas de telemedicina pagas. 

Pode ir acompañado de dor.
relevance score : -100.0%
References
Livedoid vasculopathy: A review with focus on terminology and pathogenesis 36285834 NIH
Livedoid vasculopathy é unha afección cutánea rara caracterizada por úlceras dolorosas que volven aparecer na parte inferior das pernas.
Livedoid vasculopathy (LV) is a rare thrombotic vasculopathy of the dermis characterized by painful, relapsing ulcers over the lower extremities. Diagnosis is challenging due to the overlap in clinical appearance and nomenclature with other skin disorders. Treatment selection is complicated by poor understanding of the pathogenesis of LV and lack of robust clinical trials evaluating therapy efficacy. The terminology and pathophysiology of LV are reviewed here, along with its epidemiology, clinical and histologic features, and treatment options. A diagnostic pathway is suggested to guide providers in evaluating for comorbidities, referring to appropriate specialists, and choosing from the available classes of therapy.
Livedoid vasculopathy: A review of pathogenesis and principles of management 27297279Livedoid vasculopathy é unha afección cutánea rara que causa úlceras recorrentes na parte inferior das pernas, deixando cicatrices pálidas coñecidas como atrofia branca. Aínda que a causa exacta aínda non está clara, crese que o aumento da coagulación do sangue (hypercoagulability) é o principal factor, sendo a inflamación un papel secundario. Os factores que contribúen á coagulación inclúen os seguintes: deficiencies in proteins C and S, genetic mutations like factor V Leiden, antithrombin III deficiency, prothrombin gene mutations, high levels of homocysteine. Nas biopsias, a condición mostra coágulos de sangue dentro dos vasos, engrosamento das paredes dos vasos e cicatrices. O tratamento implica un enfoque multifacético centrado na prevención de coágulos sanguíneos con medicamentos como antiplaquetarios, anticoagulantes e terapia fibrinolítica. Pódense usar varios medicamentos para esta condición da pel - colchicine and hydroxychloroquine, vasodilators, immunosuppressants.
Livedoid vasculopathy is a rare skin condition that causes recurring ulcers on the lower legs, leaving behind pale scars known as atrophie blanche. While the exact cause is still unclear, it's believed that increased blood clotting (hypercoagulability) is the main factor, with inflammation playing a secondary role. Factors contributing to clotting include as follows - deficiencies in proteins C and S, genetic mutations like factor V Leiden, antithrombin III deficiency, prothrombin gene mutations, high levels of homocysteine. In biopsies, the condition shows blood clots inside vessels, thickening of vessel walls, and scarring. Treatment involves a multi-pronged approach focusing on preventing blood clots with medications like anti-platelet drugs, blood thinners, and fibrinolytic therapy. Various drugs can be used for this skin condition - colchicine and hydroxychloroquine, vasodilators, immunosuppressants.
Livedoid Vasculopathy 32644463 NIH
Livedoid vasculopathy é unha condición rara na que se producen lesións en ambas as pernas. Pénsase que a formación de coágulos de sangue en pequenos vasos sanguíneos é causada polo aumento da coagulación e a redución da degradación dos coágulos, xunto co dano no revestimento dos vasos. É máis común nas mulleres, especialmente entre os 15 e os 50 anos. Deixar de fumar, coidar as feridas e usar medicamentos como anticoagulantes e antiagregantes foron efectivos.
Livedoid vasculopathy is a rare vasculopathy that is typically characterized by bilateral lower limb lesions. Increased thrombotic activity and decreased fibrinolytic activity along with endothelial damage are believed to be the cause of thrombus formation in the capillary vasculature. It is 3 times more common in females than in males, especially in patients between the ages of 15 to 50 years. There is no definite first-line treatment, but general measures like smoking cessation, wound care, and pharmacological measures like anticoagulants and antiplatelets have shown good results.